REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Russell Investments Group, Ltd.'s Holding History (CIK: 0001692234)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 2,278 Value ($000) $7 Avg Close Range
Q3 2024
Shares 198 Value ($000) $1 Avg Close Range
Q2 2024
Shares 203 Value ($000) $1 Avg Close Range
Q1 2024
Shares 167 Value ($000) $1 Avg Close Range
Q3 2023
Shares 182 Value ($000) $2 Avg Close Range
Q2 2023
Shares 58,675 Value ($000) $1,485 Avg Close Range
Q1 2023
Shares 28,404 Value ($000) $915 Avg Close Range
Q4 2022
Shares 79,498 Value ($000) $1,468 Avg Close Range
Q3 2022
Shares 154,228 Value ($000) $4,161 Avg Close Range
Q2 2022
Shares 35,543 Value ($000) $490 Avg Close Range
Q1 2022
Shares 39,817 Value ($000) $775 Avg Close Range
Q4 2021
Shares 51,511 Value ($000) $840 Avg Close Range
Q2 2021
Shares 5,835 Value ($000) $172 Avg Close Range
Q1 2021
Shares 5,835 Value ($000) $163 Avg Close Range
Q3 2020
Shares 52,050 Value ($000) $1,307 Avg Close Range
Q2 2020
Shares 36,996 Value ($000) $902 Avg Close Range
Q3 2019
Shares 11,900 Value ($000) $155 Avg Close Range
Q2 2019
Shares 30,513 Value ($000) $396 Avg Close Range
Q4 2016
Shares 8,290 Value ($000) $174 Avg Close Range